Successful Management of Seizures Through a Gluten-Free Diet in a Patient with Drug-Resistant Epilepsy and Celiac Disease: A Case Study

Overview

This case study presents a 21-year-old female with drug-resistant epilepsy and celiac disease successfully managed with a gluten-free diet (GFD). Following the initiation of the GFD, the patient became seizure-free and showed significant improvement in overall health.

Background

Celiac disease (CD) is an autoimmune disorder that can lead to various neurological complications, including epilepsy. Approximately 20% of epilepsy patients experience drug-resistant seizures, highlighting the need for alternative management strategies. This case underscores the importance of screening for CD in patients with unexplained or refractory seizures, as dietary interventions may significantly improve outcomes.

Data Highlights

No numerical data available in the article.

Key Findings

• The patient had a history of drug-resistant epilepsy diagnosed as cryptogenic generalized epilepsy.
• Initial treatments with multiple antiseizure medications failed to control seizure frequency.
• Diagnosis of celiac disease was confirmed through immunological testing and duodenal biopsy.
• Initiation of a gluten-free diet led to complete resolution of seizures and improvement in overall health.
• Follow-up EEG showed complete resolution of epileptiform discharges after dietary intervention.

Clinical Implications

Healthcare providers should consider screening for celiac disease in patients with drug-resistant epilepsy, as dietary management may provide significant benefits. A gluten-free diet should be viewed as a potential therapeutic option for patients with epilepsy associated with celiac disease.

Conclusion

This case illustrates the successful management of drug-resistant epilepsy through dietary intervention in a patient with celiac disease, emphasizing the need for awareness of the potential link between these conditions.

References

1. Optometric Management, 2011 -- Reflections
2. The New Gastroenterologist, 2025 -- Celiac Disease: Recent Advances in Diagnosis and Patient Monitoring
3. The New Gastroenterologist, 2025 -- Liver-Related Manifestations of Celiac Disease
4. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach - PMC
5. Redefining drug‐resistant epilepsy: Insights from an Italian Delphi consensus study - PMC
6. Journal of Neuro-Oncology — Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study
7. European Society for the Study of Coeliac Disease 2025 Updated Guidelines on the Diagnosis and Management of Coeliac Disease in Adults. Part 1: Diagnostic Approach - PMC
8. Redefining drug‐resistant epilepsy: Insights from an Italian Delphi consensus study - PMC
9. Efficacy and safety of ketogenic diets in drug-resistant epilepsy: a systematic review and meta-analysis | World Journal of Pediatrics | Springer Nature Link